Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Joshua B. Cohen currently holds 3,643,587 shares of Amylyx Pharmaceuticals, Inc. (AMLX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joshua B. Cohen has been a net seller of AMLX stock. They have purchased $0 and sold $6.0M worth of shares.
Joshua B. Cohen's most recent insider trade was on Aug 18, 2026, when they sold 60,039 shares at $0.00 per share.
Joshua B. Cohen serves as Executive at Amylyx Pharmaceuticals, Inc. (AMLX). They have executed 29 insider transactions totaling $6.0M over their tenure at the company.
Joshua B. Cohen holds the position of Executive at Amylyx Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Joshua B. Cohen has shown a selling trading pattern, with $0 in total purchases and $6.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Joshua B. Cohen was on Mar 16, 2023, when they sold $3.1M worth of AMLX shares. This transaction involved 96,076 shares at $31.84 per share.
Joshua B. Cohen currently owns 3,643,587 shares of Amylyx Pharmaceuticals, Inc. (AMLX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Joshua B. Cohen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joshua B. Cohen has 29 Form 4 filings on record as an insider at Amylyx Pharmaceuticals, Inc..
Set alerts for Joshua B. Cohen and 40,000+ other insiders.